◀ Back to ATP5O

ATP5O — GCG

Text-mined interactions from Literome

Laroche-Joubert et al., American journal of physiology. Renal physiology 2000 (Potassium Deficiency) : In OMCDs, dD-AVP and glucagon stimulated type III but not type I K ( + ) -ATPase
Vieira et al., Diabetologia 2007 (Calcium Signaling) : Glucose suppression of glucagon release was prevented by inhibitors of the sarco ( endo ) plasmic reticulum Ca ( 2+ ) -ATPase , which abolished the [ Ca ( 2+ ) ] ( i ) -lowering effect of glucose on isolated alpha cells
Lotersztajn et al., J Biol Chem 1987 : We have previously shown that liver plasma membrane ( Ca2+-Mg2+ ) -ATPase activity is inhibited by glucagon ... Even though adenylate cyclase activity was increased by cholera toxin treatment, addition of cyclic AMP did not mimic the effect of cholera toxin in blocking glucagon mediated inhibition of ( Ca2+-Mg2+ ) -ATPase activity
Altin et al., Biochem Biophys Res Commun 1987 : Contrary to suggestions that glucagon can inhibit the Ca2+-ATPase , these results suggest that glucagon ( at concentrations up to 1 microM ) does not affect Ca2+ efflux via the Ca2+-ATPase
López-Moratalla et al., Arch Biochem Biophys 1984 : Effect of injected glucagon or fatty acids on mitochondrial ATPase ... These results suggest that the modification of the properties of mitochondrial ATPase induced by glucagon or fatty acids might be mediated by a change in the mitochondrial redox state
Yamaguchi et al., Endocrinol Jpn 1980 : The effects of calcitonin ( CT ), epinephrine and glucagon on the plasma membrane Ca-ATPase activity and the calcium content in the liver were investigated 30 min after a single subcutaneous administration of hormones to rats